InvestorsHub Logo
icon url

gwebb

04/24/11 7:23 PM

#8258 RE: Southern Gal #8257

Press Release Source: Global General Technologies Inc. On Thursday April 21, 2011, 3:45 pm EDT

HENDERSON, NEVADA--(Marketwire - 04/21/11) - Global General Technologies Inc. (PINK SHEETS:GLGT - News)(www.glgt-corporate.com) is pleased to announce the completion of its merger with Wuhan, China-based biotech company AB (Wuhan) Biotech Co. Ltd.

GLGT introduced AB (Wuhan) Biotech as its merger candidate at the end of March.

AB (Wuhan) Biotech is a China-based entity with ties to the American market (Abgenom, American Centrality Croup, Inc.). The company focuses on research and development, production and marketing mainly for Chinese market. Its principal objective is to become a leading supplier in molecular diagnosis and home-applicable end-user In Vitro Diagnostic (IVD) markets. The ultimate goal is to be the leader in developing and producing high quality, cutting-edge diagnostic products for various human diseases.

AB (Wuhan) Biotech is committed to developing, commercializing and popularizing advanced IVD kits/devices to improve human health. Its primary business is to design, develop, patent and market home-applicable diagnostic test papers and portable diagnostic devices related to cardiovascular diseases.

GLGT and AB Wuhan Biotech will soon update investors and followers of additional developments, including revenues, assets and merger details (including new management), through a separate filing and/or a news release.
icon url

sportynorty5

04/24/11 9:12 PM

#8280 RE: Southern Gal #8257

Yes they do have revenues and assets per the company PR